Azithromycin in bronchiolitis obliterans: Is the evidence strong enough? [3]

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 4, 2006, Pages 465-466

  Angel, Luis F ^a   Levine, Deborah ^a   Sanchez, Juan ^a   Levine, Stephanie ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

AIRWAY OBSTRUCTION; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; FORCED EXPIRATORY VOLUME; GENERAL CONDITION IMPROVEMENT; HUMAN; LETTER; LUNG FUNCTION TEST; LUNG GRAFT REJECTION; PRIORITY JOURNAL;

EID: 32444448395     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/ajrccm.173.4.465     Document Type: Letter

References (3)

1. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003;168:121-125.
2. Yates B, Murphy DM, Forrest IA, Ward C, Rutherford RM, Fisher AJ, Lordan JL,Dark JH, Corris PA. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005;172:772-775.
3. Williams TJ, Verleden GM. Azithromycin: a plea for multicenter randomized studies in lung transplantation. Am J Respir Crit Care Med 2005;172:657-659.